Primary leiomyosarcoma of the prostate is extremely rare. It accounts for less than 0.1% of prostate neoplasms and has a poor prognosis. Most patients are presented with obstructive symptoms, perineal pain, burning on ejaculation, and weight loss. Multimodality treatment combinations including surgery like prostatectomy or cystoprostatectomy, preopreoperative or postoperative radiation therapy, and neoadjuvant or adjuvant chemotherapy have been used in the management of leiomyosarcomas of the prostate, but there are no standard treatment recommendations. Herein, we present a 62-year-old male suffering from recurrent hematuria and rapidly progressive prostatism, diagnosed as leiomyosarcoma of the prostate
Radiation therapy (RTx) has been employed as a curative therapy for prostatic adenocarcinoma. RTx-in...
License, which permits unrestricted use, distribution, and reproduction in anymedium, provided the o...
Contains fulltext : 186322.pdf (publisher's version ) (Open Access)A pure leiomyom...
Primary leiomyosarcoma of the prostate is extremely rare. It accounts for less than 0.1% of prostate...
Primary leiomyosarcoma of the prostate is extremely rare. It accounts for less than 0.1% of prostate...
Prostate leiomyosarcoma is an extremely rare and highly aggressive neoplasm that accounts for less t...
Leiomyosarcoma of the prostate is a rare entity. It is the most common prostate sarcoma in the elder...
Leiomyosarcoma of prostate is rare accounting for 0.1% of prostatic malignancies. It has a very poor...
Primary leiomyosarcoma of the prostate (PLSOP) is rare, with less than 200 cases reported so far. PL...
Prostatic Leiomyosarcoma is a rare tumor with less than 200 cases reported. These are aggressive tum...
Leiomyosarcoma of the prostate is an extremely rare entity. Sarcomas account for about 1% of all mal...
Leiomyosarcoma (LMS) of the prostate is an extremely rare and aggressive tumor that presents with no...
A 55-year-old man was admitted because of difficult ur i n ation. Biopsy of the prostate revealed un...
Leiomyosarcoma is a rare neoplasm with a poor survival rate. Between June 2018 to January 2019 we tr...
Patient. A 65-year old man who had previously undergone surgery for benign prostatic hyperplasia pre...
Radiation therapy (RTx) has been employed as a curative therapy for prostatic adenocarcinoma. RTx-in...
License, which permits unrestricted use, distribution, and reproduction in anymedium, provided the o...
Contains fulltext : 186322.pdf (publisher's version ) (Open Access)A pure leiomyom...
Primary leiomyosarcoma of the prostate is extremely rare. It accounts for less than 0.1% of prostate...
Primary leiomyosarcoma of the prostate is extremely rare. It accounts for less than 0.1% of prostate...
Prostate leiomyosarcoma is an extremely rare and highly aggressive neoplasm that accounts for less t...
Leiomyosarcoma of the prostate is a rare entity. It is the most common prostate sarcoma in the elder...
Leiomyosarcoma of prostate is rare accounting for 0.1% of prostatic malignancies. It has a very poor...
Primary leiomyosarcoma of the prostate (PLSOP) is rare, with less than 200 cases reported so far. PL...
Prostatic Leiomyosarcoma is a rare tumor with less than 200 cases reported. These are aggressive tum...
Leiomyosarcoma of the prostate is an extremely rare entity. Sarcomas account for about 1% of all mal...
Leiomyosarcoma (LMS) of the prostate is an extremely rare and aggressive tumor that presents with no...
A 55-year-old man was admitted because of difficult ur i n ation. Biopsy of the prostate revealed un...
Leiomyosarcoma is a rare neoplasm with a poor survival rate. Between June 2018 to January 2019 we tr...
Patient. A 65-year old man who had previously undergone surgery for benign prostatic hyperplasia pre...
Radiation therapy (RTx) has been employed as a curative therapy for prostatic adenocarcinoma. RTx-in...
License, which permits unrestricted use, distribution, and reproduction in anymedium, provided the o...
Contains fulltext : 186322.pdf (publisher's version ) (Open Access)A pure leiomyom...